The Global Osteoarthritis Drugs Market Continues To Grow Owing To the Increased Incidents of Rheumatoid Arthritis in Patients and Institutional Initiatives to Collaborate With Key Players
Osteoarthritis Drugs include non-steroidal anti-inflammatory drugs (NSAIDs), which are usually used in cases where there is an acute onset of pain in the joint. Osteoarthritis is also commonly known as Degenerative Joint Disease (DRD) and is caused due to wear and tear of the joints. Osteoarthritis involves the wearing away of cartilage which prevents the knee to bend properly or fully. It usually occurs in large bone joints like hips, hands, wrists, and knees; however, it can also affect the small bone joints like finger joints, shoulders, and toes. Osteoarthritis causes swelling and redness of the joints, making the patient susceptible to injuries and further aggravate the condition. Some Osteoarthritis Drugs like Delexan, Glucosamine, and Chondroitin Sulfate are used to reduce inflammation of the joints by neutralizing and controlling the enzymes that cause inflammation in the joints. In certain cases, the Osteoarthritis Drugs like Motrin, Advil, and Tylenol can be used for re...